Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2023
Spectrum and Excess Risk of Gastrointestinal Tumors in Li-Fraumeni SyndromeJessica N Hatton, Kelvin C de Andrade, Megan N Frone, et al.
Frontiers in Oncology|November 22, 2024
Characterization of sarcoma topography in Li-Fraumeni syndromeKarin J Brockman, Mone't B Thompson, Lisa Mirabello, et al.
Journal of the National Cancer Institute|January 23, 2026
Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendationsChristian P Kratz, Megan N Frone, Payal P Khincha, et al.
The Lancet. Oncology|November 15, 2021
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort studyKelvin César de Andrade, Payal P Khincha, Jessica N Hatton, et al.
Genetics in Medicine Open|July 29, 2024
A genome-first approach to characterize DICER1 pathogenic variant prevalence, penetrance and cancer, thyroid, and other phenotypes in 2 population-scale cohortsJung Kim, Jeremy Haley, Jessica N Hatton, et al.
JNCI Cancer Spectrum|October 21, 2022
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant CarriersMichael R Sargen, Hildur Helgadottir, Xiaohong R Yang, et al.
JCO Precision Oncology|October 26, 2023
Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell TumorClaudette R Fraire, Paige R Mallinger, Jessica N Hatton, et al.
HGG Advances|October 1, 2023
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variantsKelvin C de Andrade, Natasha T Strande, Jung Kim, et al.
JAMA Dermatology|May 27, 2026
Prevalence of Familial Melanoma Genes and Cancer Risk Among Genomically Ascertained IndividualsAlisa M Goldstein, Jung Kim, Jeremy S Haley, et al.
JCO Precision Oncology|April 23, 2025
Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell TumorAlexander T Nelson, Dave Watson, Kenneth S Chen, et al.
Pageof 2